APOL1 and gastric adenocarcinoma: The results indicated significantly higher APOL1 levels in breast invasive carcinoma, colon adenocarcinoma, HNSC, kidney renal clear cell carcinoma, kidney renal papillary cell carcinoma, stomach adenocarcinoma and THCA (Figures 1B, C).